Cargando…
Rifampin- and Multidrug-Resistant Tuberculosis in Russian Civilians and Prison Inmates: Dominance of the Beijing Strain Family
Consecutive patient cultures (140) of Mycobacteriium tuberculosis were collected from five Russian civilian and prison tuberculosis laboratories and analyzed for rifampin (rpoB) and isoniazid resistance (inhA, katG, ahpC); transmission of Beijing family isolates; and the importance of prison and pre...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2738537/ https://www.ncbi.nlm.nih.gov/pubmed/12453364 http://dx.doi.org/10.3201/eid0811.020507 |
_version_ | 1782171520578093056 |
---|---|
author | Drobniewski, Francis Balabanova, Yanina Ruddy, Michael Weldon, Laura Jeltkova, Katya Brown, Timothy Malomanova, Nadezdna Elizarova, Elvira Melentyey, Alexander Mutovkin, Ebgeny Zhakharova, Svetlana Fedorin, Ivan |
author_facet | Drobniewski, Francis Balabanova, Yanina Ruddy, Michael Weldon, Laura Jeltkova, Katya Brown, Timothy Malomanova, Nadezdna Elizarova, Elvira Melentyey, Alexander Mutovkin, Ebgeny Zhakharova, Svetlana Fedorin, Ivan |
author_sort | Drobniewski, Francis |
collection | PubMed |
description | Consecutive patient cultures (140) of Mycobacteriium tuberculosis were collected from five Russian civilian and prison tuberculosis laboratories and analyzed for rifampin (rpoB) and isoniazid resistance (inhA, katG, ahpC); transmission of Beijing family isolates; and the importance of prison and previous therapy in drug resistance. Rifampin, isoniazid, and multidrug resistance occurred in 58.2%, 51.6%, and 44.7% of cultures, respectively; 80% of prison cultures were rifampin resistant. Spoligotyping and variable number tandem repeat (VNTR) fingerprinting divided the isolates into 43 groups. Spoligotyping demonstrated that a high proportion (68.1%) of patients were infected with Beijing family strains and that most (69.1%) were rifampin resistant; the highest proportion (81.6%) occurred in prison. One VNTR subgroup (42435) comprised 68 (72.3%) of the Beijing isolates with a small number of IS6110 types; 50 (73.5%) were rifampin resistant. Rifampin-resistant Beijing isolates are dominant within the patient population, especially among prisoners, and threaten treatment programs. |
format | Text |
id | pubmed-2738537 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2002 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-27385372009-09-16 Rifampin- and Multidrug-Resistant Tuberculosis in Russian Civilians and Prison Inmates: Dominance of the Beijing Strain Family Drobniewski, Francis Balabanova, Yanina Ruddy, Michael Weldon, Laura Jeltkova, Katya Brown, Timothy Malomanova, Nadezdna Elizarova, Elvira Melentyey, Alexander Mutovkin, Ebgeny Zhakharova, Svetlana Fedorin, Ivan Emerg Infect Dis Research Consecutive patient cultures (140) of Mycobacteriium tuberculosis were collected from five Russian civilian and prison tuberculosis laboratories and analyzed for rifampin (rpoB) and isoniazid resistance (inhA, katG, ahpC); transmission of Beijing family isolates; and the importance of prison and previous therapy in drug resistance. Rifampin, isoniazid, and multidrug resistance occurred in 58.2%, 51.6%, and 44.7% of cultures, respectively; 80% of prison cultures were rifampin resistant. Spoligotyping and variable number tandem repeat (VNTR) fingerprinting divided the isolates into 43 groups. Spoligotyping demonstrated that a high proportion (68.1%) of patients were infected with Beijing family strains and that most (69.1%) were rifampin resistant; the highest proportion (81.6%) occurred in prison. One VNTR subgroup (42435) comprised 68 (72.3%) of the Beijing isolates with a small number of IS6110 types; 50 (73.5%) were rifampin resistant. Rifampin-resistant Beijing isolates are dominant within the patient population, especially among prisoners, and threaten treatment programs. Centers for Disease Control and Prevention 2002-11 /pmc/articles/PMC2738537/ /pubmed/12453364 http://dx.doi.org/10.3201/eid0811.020507 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Research Drobniewski, Francis Balabanova, Yanina Ruddy, Michael Weldon, Laura Jeltkova, Katya Brown, Timothy Malomanova, Nadezdna Elizarova, Elvira Melentyey, Alexander Mutovkin, Ebgeny Zhakharova, Svetlana Fedorin, Ivan Rifampin- and Multidrug-Resistant Tuberculosis in Russian Civilians and Prison Inmates: Dominance of the Beijing Strain Family |
title | Rifampin- and Multidrug-Resistant Tuberculosis in Russian Civilians and Prison Inmates: Dominance of the Beijing Strain Family |
title_full | Rifampin- and Multidrug-Resistant Tuberculosis in Russian Civilians and Prison Inmates: Dominance of the Beijing Strain Family |
title_fullStr | Rifampin- and Multidrug-Resistant Tuberculosis in Russian Civilians and Prison Inmates: Dominance of the Beijing Strain Family |
title_full_unstemmed | Rifampin- and Multidrug-Resistant Tuberculosis in Russian Civilians and Prison Inmates: Dominance of the Beijing Strain Family |
title_short | Rifampin- and Multidrug-Resistant Tuberculosis in Russian Civilians and Prison Inmates: Dominance of the Beijing Strain Family |
title_sort | rifampin- and multidrug-resistant tuberculosis in russian civilians and prison inmates: dominance of the beijing strain family |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2738537/ https://www.ncbi.nlm.nih.gov/pubmed/12453364 http://dx.doi.org/10.3201/eid0811.020507 |
work_keys_str_mv | AT drobniewskifrancis rifampinandmultidrugresistanttuberculosisinrussianciviliansandprisoninmatesdominanceofthebeijingstrainfamily AT balabanovayanina rifampinandmultidrugresistanttuberculosisinrussianciviliansandprisoninmatesdominanceofthebeijingstrainfamily AT ruddymichael rifampinandmultidrugresistanttuberculosisinrussianciviliansandprisoninmatesdominanceofthebeijingstrainfamily AT weldonlaura rifampinandmultidrugresistanttuberculosisinrussianciviliansandprisoninmatesdominanceofthebeijingstrainfamily AT jeltkovakatya rifampinandmultidrugresistanttuberculosisinrussianciviliansandprisoninmatesdominanceofthebeijingstrainfamily AT browntimothy rifampinandmultidrugresistanttuberculosisinrussianciviliansandprisoninmatesdominanceofthebeijingstrainfamily AT malomanovanadezdna rifampinandmultidrugresistanttuberculosisinrussianciviliansandprisoninmatesdominanceofthebeijingstrainfamily AT elizarovaelvira rifampinandmultidrugresistanttuberculosisinrussianciviliansandprisoninmatesdominanceofthebeijingstrainfamily AT melentyeyalexander rifampinandmultidrugresistanttuberculosisinrussianciviliansandprisoninmatesdominanceofthebeijingstrainfamily AT mutovkinebgeny rifampinandmultidrugresistanttuberculosisinrussianciviliansandprisoninmatesdominanceofthebeijingstrainfamily AT zhakharovasvetlana rifampinandmultidrugresistanttuberculosisinrussianciviliansandprisoninmatesdominanceofthebeijingstrainfamily AT fedorinivan rifampinandmultidrugresistanttuberculosisinrussianciviliansandprisoninmatesdominanceofthebeijingstrainfamily |